本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

64.78
+1.302.05%
成交量:16.83萬
成交額:1,087.82萬
市值:61.06億
市盈率:-135.97
高:65.39
開:64.45
低:63.97
收:63.48
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:0.57
換手率:0.18%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:249.02
市盈率(LYR):-226.23

資料載入中...

2026/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/09

重要事件披露

Form 8-K - Current report